XML 32 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. BALANCE SHEET ACCOUNTS
9 Months Ended
Sep. 30, 2012
Notes to Financial Statements  
2. BALANCE SHEET ACCOUNTS

Capitalized software consists of the following:

 

The Company began capitalizing the development of the costs associated with its Mobile platform on October 1, 2011.  The Company demonstrated technological feasibility through the presentation of its working model of the software product.  During the nine months ended September 30, 2012, the Company capitalized $749,160 of costs incurred to continue the development of its platform and AppBlocks.  The Company will continue to capitalize costs associated with the further development of additional AppBlocks (functional components) for its Mobile platform.  The Company officially released the product platform on February 28, 2012 and began amortizing the capitalized costs at that date on a straight-line basis over a seven-year period, which is anticipated to approximate the economic life of the current platform. 

 

   

September 30,

2012

   

December 31,

2011

 
Capitalized software   $ 921,670       172,510  
Less Accumulated amortization     (48,439 )     -  
Capitalized software, net   $ 873,231       172,510  

 

Intangible assets consist of the following:

 

   

September 30,

2012

   

December 31,

2011

 
Software license   $ 108,534       108,534  
Patent development costs     26,399       9,151  
Less Accumulated amortization     (9,044 )     -  
Intangible assets, net   $ 125,889       117,685  

 

Amortization expense for the three and nine months ended September 30, 2012 and 2011 were $30,069 and $57,483 for 2012 and $-0- and $-0- for 2011, respectively

 

Accrued Liabilities

 

Accrued liabilities, including the accrued liabilities related to the Company’s litigation related to certain Nouri Parties (see Note 4 below), consisted of the following:

 

    September 30,     December 31,  
    2012     2011  
Nouri legal fee settlement   67,227      $ 217,227  
Accrued payroll and related costs     40,838       -  
Custom accounting development cost     75,436       75,436  
Hosting service costs     -       27,444  
Professional services     12,430       3,791  
Interest payable to IDB and Bondholders (See Note 3)     271,414       179,569  
Other accrued items     5,508       17,500  
    $ 472,853     $ 520,967  

 

Settlement related financial instrument liability:

 

The Company generally does not use derivative instruments to hedge exposures to cash-flow risks or market risks that may affect the fair values of its financial instruments. However, in connection with the Company’s Class Action lawsuit settlement approved by the District Court on July 1, 2011, we are required to issue 1,475,000 shares of our common stock to the Class Action class.  Through July 1, 2011, our liability related to these shares was accounted for as an accrued liability on our balance sheet and changes in the value of the shares were generally not reflected on our statements of operations, absent certain significant events, such as the approval of the settlement.  Now that the Class Action has been settled, and because we have not yet issued the shares, the liability is now accounted for as a financial instrument liability on our balance sheet and, until the shares are issued, changes in their value will be reflected on our statements of operations as losses or gains, as applicable. The number of shares to be issued will not change, and these losses or gains are not cash items that will impact our income or loss from operations.

 

The following tabular presentation reflects the components of derivative assets and liabilities as of September 30, 2012 and December 31, 2011:

 

   

September 30,

2012

   

December 31,

2011

 
Shares into which financial instrument liability can be settled:                
Unrestricted shares of common stock, when issued     1,475,000       1,475,000  

 

   

September 30,

2012

   

December 31,

2011

 
Settlement related financial instrument liability at fair value:            
Fair value of unrestricted shares of common stock   $ 2,212,500     $ 1,770,000  
                 

 

The following tabular presentation reflects the (loss) in the fair value of financial instruments for the three and nine months ended September 30, 2012 and 2011:

 

    Three Months Ended September 30,   Nine Months Ended September 30,  
    2012     2011     2012     2011  
Change in market value of settlement related financial instruments in the accompanying statement of operations is related to the Class Action settlement approved by the District Court on July 1, 2011                                
Unrestricted shares of common stock   $ -     $ 295,000     $ 442,500     $ 295,000